17-82081778-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004104.5(FASN):c.6229G>A(p.Asp2077Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000484 in 1,612,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D2077H) has been classified as Uncertain significance.
Frequency
Consequence
NM_004104.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASN | ENST00000306749.4 | c.6229G>A | p.Asp2077Asn | missense_variant | Exon 37 of 43 | 1 | NM_004104.5 | ENSP00000304592.2 | ||
FASN | ENST00000634990.1 | c.6223G>A | p.Asp2075Asn | missense_variant | Exon 37 of 43 | 5 | ENSP00000488964.1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152144Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000686 AC: 17AN: 247912 AF XY: 0.0000519 show subpopulations
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1460284Hom.: 0 Cov.: 42 AF XY: 0.0000289 AC XY: 21AN XY: 726460 show subpopulations
GnomAD4 genome AF: 0.000236 AC: 36AN: 152262Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74452 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.6229G>A (p.D2077N) alteration is located in exon 37 (coding exon 36) of the FASN gene. This alteration results from a G to A substitution at nucleotide position 6229, causing the aspartic acid (D) at amino acid position 2077 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epileptic encephalopathy Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 2077 of the FASN protein (p.Asp2077Asn). This variant is present in population databases (rs141935205, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with developmental disorders (PMID: 33057194, 35982159). ClinVar contains an entry for this variant (Variation ID: 462093). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at